- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.51 No.11
Vol.51 No.11 contents
Presidential Address
Development of disease-modifying therapy for neurodegenerative diseases
Gen Sobue, M.D.
CLINICA NEUROL, 51: 821|824, 2011
Special Lecture 1
Past, present, and future of polyglutamine expansion disease
Kenneth H. Fischbeck
CLINICA NEUROL, 51: 825|825, 2011
Special Lecture 2
Single molecule meets brain: A new concept to understand complex bio-system
Toshio Yanagida, Ph.D.
CLINICA NEUROL, 51: 826|826, 2011
Educational Lecture 1
Healthcare mediation model for nerologists
Tetsuo Ando, M.D.
CLINICA NEUROL, 51: 827|829, 2011
Educational Lecture 2
Ethical guidelines for clinical studies: overview
Yoshihiko Iijima, M.D., Ph.D.
CLINICA NEUROL, 51: 830|833, 2011
Educational Lecture 3
Pareneoplastic neurological syndrome-update-
Takashi Inuzuka, M.D., Ph.D., Yuichi Hayashi, M.D., Ph.D. and Akio Kimura, M.D., Ph.D.
CLINICA NEUROL, 51: 834|837, 2011
Educational Lecture 4
Multiple system atrophy-synuclein and neuronal degeneration
Mari Yoshida, M.D.
CLINICA NEUROL, 51: 838|842, 2011
Educational Lecture 4
Initial cellular target in multiple system atrophy: Glial cell
Mitsunori Yamada, M.D.
CLINICA NEUROL, 51: 843|843, 2011
Educational Lecture 5
Frontotemporal lobar degeneration (FTLD) concept and classification update
Imaharu Nakano, M.D.
CLINICA NEUROL, 51: 844|847, 2011
Educational Lecture 6
Central nervous system diseases in immunocompromised host
Shuji Kishida, M.D.
CLINICA NEUROL, 51: 848|848, 2011
Educational Lecture 7
Glycobiology and neurological disorders
Tatsuro Mutoh, M.D., Ph.D.
CLINICA NEUROL, 51: 849|852, 2011
Educational Lecture 8
Clinical trial updates for malignant brain tumors
Toshihiko Wakabayashi, M.D., Ph.D.
CLINICA NEUROL, 51: 853|856, 2011
Educational Lecture 9
Pharmacologic therapies of BPSD: messages from psychiatrists
Mamoru Hashimoto, M.D., Ph.D.
CLINICA NEUROL, 51: 857|860, 2011
Educational Lecture 10
Assessment of cognitive and emotional functions in Parkinson's disease
Mitsuru Kawamura, M.D.1), Mutsutaka Kobayakawa, M.D.1)2) and Natsuko Tsuruya, M.D.1)
CLINICA NEUROL, 51: 861|861, 2011
Educational Lecture 11
Secondary prevention of ischemic stroke-Update
Kortaro Tanaka, M.D.
CLINICA NEUROL, 51: 862|862, 2011
Educational Lecture 12
The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach
Hirohisa Watanabe, M.D.1), Mari Yoshida, M.D.2), Shinji Naganawa, M.D.3) and Gen Sobue, M.D.1)
CLINICA NEUROL, 51: 863|864, 2011
Educational Lecture 13
Practical genetic counseling conducted by clinical neurologist
Kunihiro Yoshida, M.D.
CLINICA NEUROL, 51: 865|867, 2011
Educational Lecture 14
Significance of COI disclosure in medical research in Japan
Saburo Sone, M.D.
CLINICA NEUROL, 51: 868|871, 2011
Educational Lecture 15
The pathophysiology and treatment of autoimmune neuromuscular junction diseases
Masakatsu Motomura, M.D.
CLINICA NEUROL, 51: 872|876, 2011
Educational Lecture 16
Diagnosis and therapies of refractory migraine
Toshihiko Shimizu, M.D., Ph.D.
CLINICA NEUROL, 51: 877|880, 2011
Symposium 1
Current state of BAD in Japan (Results of J-BAD Registry)
Haruhiko Hoshino, M.D.1), Makoto Takagi, M.D.1), Yasumasa Yamamoto, M.D.2) and J-BAD Investigators
CLINICA NEUROL, 51: 881|881, 2011
Symposium 1
Branch atheromatous disease: an important cause of small subcortical infarction in Asia
Jong Sung Kim
CLINICA NEUROL, 51: 882|882, 2011
Symposium 1
Branch atheromatous disease: prognosis and management.
The SPS3 experience
Oscar Benavente
CLINICA NEUROL, 51: 883|883, 2011
Symposium 2
A drug targeting intracellular amyloid-β and oxidative stress: Apomorphine
Yasumasa Ohyagi, M.D., Ph.D.
CLINICA NEUROL, 51: 884|887, 2011
Symposium 2
Kampo treatment for Alzheimer's disease
Hideo Hara, M.D.1) and Takeshi Tabira, M.D.2)
CLINICA NEUROL, 51: 888|888, 2011
Symposium 2
Molecular chaperone inducer: a possible treatment for Alzheimer disease
Takashi Kudo, M.D.
CLINICA NEUROL, 51: 889|889, 2011
Symposium 2
Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23
Kazuhiro Irie, Ph.D.1), Kazuma Murakami, Ph.D.1), Yuichi Masuda, Ph.D.1), Nakaba Murata2), Yoshihiro Noda2), Hiroyuki Hatsuta, M.D., Ph.D.2), Shigeo Murayama, M.D., Ph.D.2), Takahiko Shimizu, Ph.D.2), Yuko Horikoshi, Ph.D.3), Noriaki Kinoshita, Ph.D.3) and Takuji Shirasawa, M.D., Ph.D.4)
CLINICA NEUROL, 51: 890|891, 2011
Symposium 3
Disruption of interactions between immunocytes, glia and neurons in demyelinating diseases:a view from neuroscience
Tetsuya Mizuno, M.D.
CLINICA NEUROL, 51: 892|893, 2011
Symposium 3
Aberrant cross talk between immune cells and neural cells in demyelinating disorders
Yuji Nakatsuji, M.D.
CLINICA NEUROL, 51: 894|897, 2011
Symposium 3
Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease
Takuya Matsushita1), Katsuhisa Masaki2), Satoru Suzuki3), Takeshi Matsuoka2)3), Tomomi Yonekawa2), Xiao-Mu Wu4), Takeshi Tabira5), Toru Iwaki3) and Jun-ichi Kira2)
CLINICA NEUROL, 51: 898|900, 2011
Symposium 4
Registry of muscular dystrophy (Remudy). Construction of the patient self-report registry and collaboration with overseas network
Harumasa Nakamura, M.D.1) and Mitsuru Kawai, M.D.2)
CLINICA NEUROL, 51: 901|902, 2011
Symposium 4
JaCALS: a prospective multicenter ALS cohort study
Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Fumiaki Tanaka and Gen Sobue
CLINICA NEUROL, 51: 903|905, 2011
Symposium 4
The cohort study of dementia: the Hisayama study
Yutaka Kiyohara, MD, PhD
CLINICA NEUROL, 51: 906|909, 2011
Symposium 4
Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy
Yaeko Ichikawa, M.D., Ph.D., Jun Goto, M.D., Ph.D., Yasuo Nakahara, M.D., Ph.D., Jun Mitsui, M.D., Ph.D. and Shoji Tsuji, M.D., Ph.D.
CLINICA NEUROL, 51: 910|913, 2011
Symposium 5
Exon-skipping therapy for Duchenne muscular dystrophy
Shin'ichi Takeda, M.D.
CLINICA NEUROL, 51: 914|916, 2011
Symposium 5
Novel pathomechanism and therapeutic approach for Fukuyama muscular dystrophy
Tatsushi Toda, M.D.
CLINICA NEUROL, 51: 917|917, 2011
Symposium 5
Emerging novel therapeutic strategy for α-dystroglycanopathy by Large
Fumiaki Saito, M.D., Ph.D.
CLINICA NEUROL, 51: 918|921, 2011
Symposium 5
Skeletal muscle regeneration therapy
Yutaka Ohsawa, M.D.
CLINICA NEUROL, 51: 922|922, 2011
Symposium 6
Neuronal mechanisms of functional recovery after spinal cord injury and restoring lost function using artificial neuronal connection
Yukio Nishimura, Ph.D.
CLINICA NEUROL, 51: 923|923, 2011
Symposium 6
Neurorehabilitative intervention with neurofeedback system using functional near-infrared spectroscopy
Masahito Mihara, M.D., Ph.D.
CLINICA NEUROL, 51: 924|926, 2011
Symposium 6
Possibility of Brain-Computer Interface in Neurorehabilitation
Junichi Ushiba, M.D.
CLINICA NEUROL, 51: 927|927, 2011
Symposium 7
Atypical method for understanding dementia. How can studying epigenetics contribute?
Atsushi Iwata, M.D., Ph.D.
CLINICA NEUROL, 51: 928|929, 2011
Symposium 7
Clinical approach to atypical typer of dementia
Kyoko Suzuki, M.D.
CLINICA NEUROL, 51: 930|933, 2011
Symposium 7
Neurodegenerative disease presenting motor speech disorder due to pseudobulbar palsy
Kenji Ishihara, M.D.
CLINICA NEUROL, 51: 934|934, 2011
Symposium 7
Dementia with motor neuron disease
Michael J. Strong1), Wencheng Yang1), May Gohar2) and Wendy L. Strong2)
CLINICA NEUROL, 51: 935|935, 2011
Symposium 8
Neuropathic pain-definition, mechanisms diagnosis and management
Ralf Baron
CLINICA NEUROL, 51: 936|936, 2011
Symposium 8
Central neuropathic pain after surgical resection in patients with spinal intramedullary tumor
Masaya Nakamura, M.D., Osahiko Tsuji, M.D., Naobumi Hosogane, M.D., Kota Watanebe, M.D., Takashi Tsuji, M.D., Ken Ishii, M.D., Yoshiaki Toyama, M.D., Kazuhiro Chiba, M.D. and Morio Matsumoto, M.D.
CLINICA NEUROL, 51: 937|938, 2011
Symposium 8
Conservative therapy for Neuropathic Pain
Takahiro Ushida, M.D., Makoto Nishihara, M.D., Kenichi Arai, M.D. and Shinsuke Inoue, M.D.
CLINICA NEUROL, 51: 939|939, 2011
Symposium 9
Subcortical vascular dementia: Significance in the differential diagnosis of dementia
Hidekazu Tomimoto, M.D.
CLINICA NEUROL, 51: 940|942, 2011
Symposium 9
TGF-β family signaling contributes to human cerebral small vessel disease
Osamu Onodera, M.D., Ph.D.
CLINICA NEUROL, 51: 943|944, 2011
Symposium 9
The pathomechanism and treatment of CADASIL
Makoto Uchino
CLINICA NEUROL, 51: 945|948, 2011
Symposium 10
Brain MRI: differences between 3T and 1.5T
Yukio Miki, M.D.
CLINICA NEUROL, 51: 949|950, 2011
Symposium 10
Researches for diagnostic neuroradiology focusing on signals and shapes
Shoichi Ito, M.D., Ph.D.
CLINICA NEUROL, 51: 951|954, 2011
Symposium 10
Clinical application of diffusion MR imaging of the brain
Shigeki Aoki, M.D.1), Masaaki Hori, M.D.1), Yoshitaka Masutani, M.D.2), Osamu Abe, M.D.3), Koji Kamagata, M.D.1) and Takaaki Hattori, M.D.4)
CLINICA NEUROL, 51: 955|955, 2011
Symposium 11
Attracting the best and brightest to careers in neurology
Donald H. Silberberg
CLINICA NEUROL, 51: 956|956, 2011
Symposium 11
Medical neurology/critical neurology
Fumio Kanda, M.D.
CLINICA NEUROL, 51: 957|957, 2011
Symposium 11
Expert/neurologist∼clinical
Mikio Shoji, M.D.
CLINICA NEUROL, 51: 958|958, 2011
Symposium 11
Disease-oriented neuroscience researcher
Hideki Mochizuki, M.D.
CLINICA NEUROL, 51: 959|959, 2011
Symposium 12
Myositis-specific and associated autoantibodies
Masataka Kuwana, M.D.
CLINICA NEUROL, 51: 960|960, 2011
Symposium 12
Anti-SRP myopathy
Shigeaki Suzuki, M.D., Ph.D.
CLINICA NEUROL, 51: 961|963, 2011
Symposium 12
Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)
Naoki Suzuki, M.D.1), Maki Tateyama, M.D.1), Hitoshi Warita, M.D.1), Rumiko Izumi, M.D.1), Ichizo Nishino, M.D.2) and Masashi Aoki, M.D.1)
CLINICA NEUROL, 51: 964|966, 2011
Symposium 12
Immunotherapy of myositis: Future prospects
Jun Shimizu, M.D.
CLINICA NEUROL, 51: 967|967, 2011
Symposium 13
Overview for personal genome analysis
Tatsushi Toda, M.D.1) and Shoji Tsuji, M.D.2)
CLINICA NEUROL, 51: 968|968, 2011
Symposium 13
Perspectives of personal genome information analysis
Shinichi Morishita, M.D.
CLINICA NEUROL, 51: 969|969, 2011
Symposium 13
Next-generation analysis on hereditary neurodegenerative disorders using next-generation sequencers
Hiroyuki Ishiura, M.D., Ph.D.1)2) and Shoji Tsuji, M.D., Ph.D.1)
CLINICA NEUROL, 51: 970|972, 2011
Symposium 13
Genetics of sporadic disease: insights from high-throughput sequencing-Parkinson disease-
Jun Mitsui, M.D.
CLINICA NEUROL, 51: 973|974, 2011
Symposium 13
Ethical issues of personal genome research
Kazuto Kato, Ph.D
CLINICA NEUROL, 51: 975|975, 2011
Symposium 14
Neurodegeration based on polyglutamine aggregation
Nobuyuki Nukina, M.D.
CLINICA NEUROL, 51: 976|978, 2011
Symposium 14
DNA repair and neurodegeneration: a common pathology shared by polyglutamine diseases
Hitoshi Okazawa, M.D.
CLINICA NEUROL, 51: 979|981, 2011
Symposium 14
TGF-beta signaling in neurodegenerative diseases
Masahisa Katsuno, M.D.1), Haruhiko Banno, M.D.1)2), Keisuke Suzuki, M.D.1) ,Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1) and Gen Sobue, M.D.1)
CLINICA NEUROL, 51: 982|985, 2011
Symposium 14
The pathomechanisms of young-onset Parkinson's disease (PD), approach to the causes of PD form the mechanisms of insulin secretion system
Nobutaka Hattori, M.D.1), Hiroto Eguchi, M.D.1), Mika Imaizumi, Ph.D.2), Shinji Saiki, M.D.1), Shigeto Sato, M.D.1) and Shinya Nagamatsu, M.D.2)
CLINICA NEUROL, 51: 986|987, 2011
Symposium 14
Neurodegenerative disorder as "mitochondrial dysfunction disease"
Noriyuki Matsuda, Ph.D. and Keiji Tanaka, M.D.
CLINICA NEUROL, 51: 988|988, 2011
Symposium 15
Management of adult patients with childhood-onset epilepsy by child neurologists and adult neurologists
Yoko Ohtsuka, M.D.
CLINICA NEUROL, 51: 989|989, 2011
Symposium 15
Vagus nerve stimulation for epilepsy
Kensuke Kawai, M.D., Ph.D., Kenichi Usami, M.D. and Nobuhito Saito, M.D., Ph.D.
CLINICA NEUROL, 51: 990|992, 2011
Symposium 15
The leading edge of epilepsy research
Akio Ikeda, M.D., Ph.D.
CLINICA NEUROL, 51: 993|996, 2011
Symposium 15
An adult neurologist's update on epilepsy therapy
Hiroshi Shigeto, M.D., Ph.D.
CLINICA NEUROL, 51: 997|999, 2011
Symposium 16
Guidelines for atrial fibrillation and the "Real World"
Takeshi Yamashita, M.D.
CLINICA NEUROL, 51: 1000|1000, 2011
Symposium 16
Atrial fibrillation and cardiembolic stroke. Treatment and issue in acute phase
Masahiro Yasaka
CLINICA NEUROL, 51: 1001|1003, 2011
Symposium 16
Expectation to and problems of thrombin inhibitor
Shinichiro Uchiyama
CLINICA NEUROL, 51: 1004|1006, 2011
Symposium 16
Current status and future of anti-Xa inhibitors
Takehiko Nagao, M.D.
CLINICA NEUROL, 51: 1007|1010, 2011
Symposium 17
Perspectives in refractory diabetic and amyloid small-fiber neuropathy
Gerard Said
CLINICA NEUROL, 51: 1011|1011, 2011
Symposium 17
Therapeutic responsiveness in chronic inflammatory demyelinating polyradiculoneuropathy
Masahiro Iijima, M.D.
CLINICA NEUROL, 51: 1012|1014, 2011
Symposium 17
Therapeutic strategies for Charcot-Marie-Tooth disease
Masanori Nakagawa, M.D.
CLINICA NEUROL, 51: 1015|1018, 2011
Symposium 17
Treatment for Crow-Fukase (POEMS) syndrome
Satoshi Kuwabara, M.D.
CLINICA NEUROL, 51: 1019|1019, 2011
Symposium 17
Artificial control of blood-nerve barrier: a novel therapeutic approach to peripheral neuropathies
Takashi Kanda, M.D.
CLINICA NEUROL, 51: 1020|1022, 2011
Symposium 18
Care network supporting patients with intractable diseases
Jun-ichi Kira, M.D.
CLINICA NEUROL, 51: 1023|1023, 2011
Symposium 18
Several approaches for quality of life in intractable disease
Tetsuo Komori, M.D., Ph.D.
CLINICA NEUROL, 51: 1024|1026, 2011
Symposium 18
Countermeasures against natural disasters for patients with neurological intractable disases at home
Masatoyo Nishizawa
CLINICA NEUROL, 51: 1027|1028, 2011
Symposium 18
Report on the actual situation at centers offering support for intractable diseases and wide-area helicopter transport of ALS patiants on mechanical ventilation at The Great East Japan Earthquake
Takashi Imai
CLINICA NEUROL, 51: 1029|1030, 2011
Symposium 19
Alzheimer's disease and microglia
Makoto Higuchi, M.D., Ph.D.1), Bin Ji, Ph.D.1), Jun Maeda, Ph.D.1), Masahiro Maruyama, M.D., Ph.D.1), Maiko Ono, M.S.1), Makoto Sawada, Ph.D.2) and Tetsuya Suhara, M.D., Ph.D.1)
CLINICA NEUROL, 51: 1031|1031, 2011
Symposium 19
Astroglial protective mechanisms against ROS under brain ischemia
Shinichi Takahashi, M.D.
CLINICA NEUROL, 51: 1032|1035, 2011
Symposium 19
Demyelination and oligodendrocytes
Takayuki Itoh, M.D., Ph.D., Makoto Horiuchi, Ph.D., Kouji Wakayama, M.D., Ph.D., Aki Itoh, Ph.D. and David Pleasure, M.D.
CLINICA NEUROL, 51: 1036|1039, 2011
Symposium 20
Infection of herpes simplex virus-Clinical diagnosis and treatment for herpes virus encephalitis-
Satoshi Kamei, M.D.
CLINICA NEUROL, 51: 1040|1043, 2011
Symposium 20
Clinical diversity of HAM/TSP
Ryuji Kubota, M.D.
CLINICA NEUROL, 51: 1044|1046, 2011
Symposium 20
Subacute sclerosing panencephalitis (SSPE)
Mitsuaki Hosoya
CLINICA NEUROL, 51: 1047|1050, 2011
Symposium 20
Progressive multifocal leukoencephalopathyiPMLj
Hidehiro Mizusawa, M.D., Ph.D.1), Shuji Kishida, M.D., Ph.D.2), Masayuki Saijo, M.D., Ph.D.3), Motohiro Yukishita, M.D., Ph.D.4), Yukiko Shishido-Hara, M.D., Ph.D.5), Hirohumi Sawa, M.D., Ph.D.6), Kazuo Nagashima, M.D., Ph.D.7), Souichi Nukuzuma, Ph.D.8) and Masahito Yamada, M.D., Ph.D.9)
CLINICA NEUROL, 51: 1051|1057, 2011
Symposium 21
Neurorehabilitation and neural mechanisms underlying functional recovery after brain damage
Ichiro Miyai, M.D.
CLINICA NEUROL, 51: 1058|1058, 2011
Symposium 21
Fundamental theory and practice in stroke rehabilitation from acute stage to chronic stage
Hiroyoshi Hara, M.D.
CLINICA NEUROL, 51: 1059|1062, 2011
Symposium 21
Neuro-rehabilitation for neurological disease
Yukihiro Hara, M.D.
CLINICA NEUROL, 51: 1063|1065, 2011
Symposium 22
Treatment and management for severe dysphagia: medication, rehabilitation and surgery
Ichiro Fujishima, M.D.
CLINICA NEUROL, 51: 1066|1068, 2011
Symposium 22
Dysphagia with lateral medullary infarction (Wallenberg's syndrome)
Fumiko Oshima, M.D.
CLINICA NEUROL, 51: 1069|1071, 2011
Symposium 22
Evaluation and treatment of dysphagia in amyotrophic lateral sclerosis and Parkinson's disease
Toshiyuki Yamamoto, Ph.D.
CLINICA NEUROL, 51: 1072|1074, 2011
Symposium 23
Cell therapy for brain diseases: Perspective and future prospects
Ryosuke Takahashi, M.D. and Takayuki Kondo, M.D.
CLINICA NEUROL, 51: 1075|1077, 2011
Symposium 23
Neurodegenerative disease-specific induced pluripotent stem cell research
Haruhisa Inoue, M.D., Ph.D.
CLINICA NEUROL, 51: 1078|1078, 2011
Symposium 23
Evaluation of human iPS cells by neural differentiation and tumorigenicity
Yohei Okada, M.D., Ph.D.1)2) and Hideyuki Okano, M.D., Ph.D.2)
CLINICA NEUROL, 51: 1079|1080, 2011
Symposium 23
Cell based therapy for patients after cerebral embolism
Akihiko Taguchi, Kozue Saito, Katsufumi Kajimoto, Hiroshi Moriwaki, Yukiko Kasahara, Hiroaki Naritomi, Kotaro Miyashita and Kazuyuki Nagatsuka
CLINICA NEUROL, 51: 1081|1082, 2011
Symposium 24
Nurturing clinician investigators is the best way to innovative drug development from academia
Shunichi Fukuhara, M.D.
CLINICA NEUROL, 51: 1083|1083, 2011
Symposium 24
Drug discovery and development in academia
Toshio Miyata, M.D.
CLINICA NEUROL, 51: 1084|1084, 2011
Symposium 24
Current situation and future perspective for clinical trials in Japan
Katsuhiko Ichimaru
CLINICA NEUROL, 51: 1085|1085, 2011
Symposium 25
Overview: Diagnosis of vestibular syndromes
Genjiro Hirose, M.D., Ph.D.
CLINICA NEUROL, 51: 1086|1088, 2011
Symposium 25
Recent advancement of BPPV management
Mamoru Suzuki
CLINICA NEUROL, 51: 1089|1091, 2011
Symposium 25
Dizziness/vertigo caused by small cerebellar/brainstem strokes
Ken Johkura, M.D., Ph.D.
CLINICA NEUROL, 51: 1092|1095, 2011
Symposium 25
Human vestibular cortex
Yasushi Naito, M.D.
CLINICA NEUROL, 51: 1096|1096, 2011
Symposium 26
Seed, aggregation and propagation of abnormal proteins could explain neurodegeneration?
Shigeo Murayama, M.D., Ph.D.
CLINICA NEUROL, 51: 1097|1099, 2011
Symposium 26
The infectivity of protein misfolding diseases is reviewed by a prion disease researcher
Tetsuyuki Kitamoto, M.D.
CLINICA NEUROL, 51: 1100|1100, 2011
Symposium 26
Protein cancers hypothesis for neurodegenerative diseases
Masato Hasegawa
CLINICA NEUROL, 51: 1101|1104, 2011
Symposium 26
Cross-seeding hypothesis for mental disorders in Huntington disease-Implications from prion diseases to neuropsychiatric diseases
Motomasa Tanaka, Ph.D., Yoko Nekooki, M.S., Yusuke Komi, Ph.D. and Ryo Endo, Ph.D.
CLINICA NEUROL, 51: 1105|1105, 2011
Symposium 27
Pathophysiological roles of autophagy
Masaaki Komatsu, M.D.
CLINICA NEUROL, 51: 1106|1106, 2011
Symposium 27
The enhancement of protein degradation systems exerts therapeutic effects in the polyglutamine-mediated motor neuron disease
Hiroaki Adachi, M.D.
CLINICA NEUROL, 51: 1107|1107, 2011
Symposium 27
Selective degradation of expanded polyglutamine proteins by their specific recognition with QBP1
Yoshitaka Nagai, M.D., Ph.D.1) and Nobuyuki Nukina, M.D., Ph.D.2)
CLINICA NEUROL, 51: 1108|1110, 2011
Symposium 28
Electrodiagnosis of ALS: its practical aspects
Masahiro Sonoo, M.D.1), Mana Higashihara, M.D.2) and Keiichi Hokkoku, M.D.1)
CLINICA NEUROL, 51: 1111|1113, 2011
Symposium 28
Increased variability of membrane potentials in amyotrophic lateral sclerosis
Yoshimitsu Shimatani, M.D.1), Yoshiko Shibuta, M.D.1), Hiroyuki Nodera, M.D.1)2), Atsuko Nodera, M.D., Ph.D.1), Kotaro Asanuma, M.D., Ph.D.1), Yuishin Izumi, M.D., Ph.D.1) and Ryuji Kaji, M.D., Ph.D.1)
CLINICA NEUROL, 51: 1114|1117, 2011
Symposium 28
Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis
Kazuaki Kanai, M.D., Kazumoto Shibuya, M.D. and Satoshi Kuwabara, M.D.
CLINICA NEUROL, 51: 1118|1119, 2011
Symposium 28
Electrophysiological findings in TDP-43 over-expressed animal models
Takanori Yokota, M.D.
CLINICA NEUROL, 51: 1120|1120, 2011
Symposium 29
Physiological analysis of the cerebellum: Roles in temporal processing
Masaki Tanaka, M.D., Ph.D., Shogo Ohmae, M.D., Ph.D. and Akiko Uematsu, B.Pharin.
CLINICA NEUROL, 51: 1121|1121, 2011
Symposium 29
Dissecting molecular mechanism of spinocerebellar ataxia type 31
Kinya Ishikawa, M.D.1), Yusuke Niimi, M.D.1), Nozomu Sato, M.D.1), Takeshi Amino, M.D.1)2) and Hidehiro Mizusawa, M.D.1)
CLINICA NEUROL, 51: 1122|1124, 2011
Symposium 29
Hereditary spastic paraplegia in Japan
Yoshihisa Takiyama, M.D.
CLINICA NEUROL, 51: 1125|1128, 2011
Symposium 29
Intensive neurorehabilitation improves motor function in patients with spinocerebellar degeneration
Ichiro Miyai, M.D.
CLINICA NEUROL, 51: 1129|1129, 2011
Symposium 30
Epidemiological and clinical aspects of non-hereditary systemic amyloidosis
Yoshiki Sekijima, M.D., Ph.D.
CLINICA NEUROL, 51: 1130|1133, 2011
Symposium 30
Clinicopathological features of familial amyloid polyneuropathy
Haruki Koike and Gen Sobue
CLINICA NEUROL, 51: 1134|1137, 2011
Symposium 30
Effect of liver trasplantation on familial amyloidotic polyneuropathy (FAP) and its limt
Yukio Ando, M.D., PhD
CLINICA NEUROL, 51: 1138|1141, 2011
Symposium 30
Cerebral amyloid angiopathy: pathogenesis and clinical features
Masahito Yamada, M.D.
CLINICA NEUROL, 51: 1142|1142, 2011
Symposium 30
Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy
Shu-ichi Ikeda, M.D.
CLINICA NEUROL, 51: 1143|1145, 2011
Symposium 31
Mechanism of chronification of migraine
Norihiro Suzuki, M.D.
CLINICA NEUROL, 51: 1146|1146, 2011
Symposium 31
Clinical course and natural history in migraine
Hisanori Kowa, M.D., Ph.D. and Kenji Nakashima, M.D., Ph.D.
CLINICA NEUROL, 51: 1147|1149, 2011
Symposium 31
Treatment of refractory medication overuse headache
Junichi Hamada, M.D.
CLINICA NEUROL, 51: 1150|1152, 2011
Symposium 31
Psychosomatic approach for chronic migraine
Masahiro Hashizume
CLINICA NEUROL, 51: 1153|1155, 2011
Symposium 32
Antibody treatment for multiple sclerosis and neuromyeitis optica
Takashi Yamamura, M.D.
CLINICA NEUROL, 51: 1156|1156, 2011
Symposium 32
Anti-myostatin antibody therapy for myopathies
Yoshihide Sunada, M.D.
CLINICA NEUROL, 51: 1157|1159, 2011
Symposium 32
Antibody therapy for Alzheimer's disease
Takeshi Tabira, Shin-ei Matsumoto and Haifeng Jin
CLINICA NEUROL, 51: 1160|1161, 2011
Symposium 32
Antibody therapy targeting ALS-linked misfolded protein
Makoto Urushitani, M.D., Ph.D.
CLINICA NEUROL, 51: 1162|1164, 2011
Symposium 33
Pathophysiology and clinical presentation of Parkinson's disease-up to date pathomechanisms of Parkinson's disease
Takafumi Hasegawa, M.D.
CLINICA NEUROL, 51: 1165|1167, 2011
Symposium 33
Neuropathology
Yuko Saito, M.D., Ph.D.1) and Shigeo Murayama, M.D., Ph.D.2)
CLINICA NEUROL, 51: 1168|1171, 2011
Symposium 33
Up to date on Parkinson's disease-Therapy-
Taku Hatano, M.D.
CLINICA NEUROL, 51: 1172|1172, 2011
Symposium 34
Cerebral infarction: tissue clock and reperfusion, brief overview
Shinichi Takahashi, M.D.
CLINICA NEUROL, 51: 1173|1173, 2011
Symposium 34
The extension of time window until 4.5 hours and development of MRI in t-PA patients
Kazumi Kimura, M.D., Yuki Sakamoto, M.D. and Junya Aoki, M.D.
CLINICA NEUROL, 51: 1174|1176, 2011
Symposium 34
Proton magnetic resonance spectroscopy as a time clock measurement device in cerebral ischemia
Hironaka Igarashi, M.D., Ph.D.
CLINICA NEUROL, 51: 1178|1181, 2011
Symposium 34
Therapeutic time window for ischemic stroke
Koji Abe, M.D., Ph.D.
CLINICA NEUROL, 51: 1182|1184, 2011
Symposium 35
Molecular neuropathology of neurodegeneration by TDP-43
Takashi Nonaka, Ph.D. and Masato Hasegawa, Ph.D.
CLINICA NEUROL, 51: 1185|1185, 2011
Symposium 35
BSCL2-related neurologic disorders/seipinopathy: endoplasmic reticulum stress in neurodegeneration
Daisuke Ito, M.D., Takuya Yagi, M.D. and Norihiro Suzuki, M.D.
CLINICA NEUROL, 51: 1186|1188, 2011
Symposium 35
Role of axonal transport in ALS
Fumiaki Tanaka, M.D., Kensuke Ikenaka, M.D. and Gen Sobue, M.D.
CLINICA NEUROL, 51: 1189|1191, 2011
Symposium 35
Glial pathology in amyotrophic lateral sclerosis
Koji Yamanaka, M.D.
CLINICA NEUROL, 51: 1192|1194, 2011
Symposium 35
Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor
Masashi Aoki, M.D., Hitoshi Warita, M.D., Naoki Suzuki, M.D., Masaaki Kato, M.D. and Yasuto Itoyama, M.D.
CLINICA NEUROL, 51: 1195|1198, 2011